Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease

Mitochondrial dysfunction, oxidative stress and neuroinflammation have been implicated as key mediators contributing to the progressive degeneration of dopaminergic neurons in Parkinson’s disease (PD). Currently, we lack a pharmacological agent that can intervene in all key pathological mechanisms,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Neuroimmune Pharmacol
Hoofdauteurs: Ghosh, Anamitra, Langley, Monica R, Harischandra, Dilshan, Neal, Matthew L, Jin, Huajun, Anantharam, Vellareddy, Joseph, Joy, Brenza, Timothy, Narasimhan, Balaji, Kanthasamy, Arthi, Kalyanaraman, Balaraman, Kanthasamy, Anumantha G.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4995106/
https://ncbi.nlm.nih.gov/pubmed/26838361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11481-016-9650-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items